GTF2E1
Basic information
Region (hg38): 3:120742636-120783069
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (12 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GTF2E1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 12 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 12 | 0 | 1 |
Variants in GTF2E1
This is a list of pathogenic ClinVar variants found in the GTF2E1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-120750559-G-C | not specified | Uncertain significance (Nov 09, 2022) | ||
3-120750719-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
3-120750782-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
3-120750864-A-C | not specified | Uncertain significance (Apr 07, 2023) | ||
3-120776532-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
3-120776598-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
3-120776634-G-C | not specified | Uncertain significance (Mar 01, 2024) | ||
3-120776637-G-T | not specified | Uncertain significance (Nov 10, 2022) | ||
3-120781065-T-G | not specified | Uncertain significance (Dec 11, 2023) | ||
3-120781073-G-A | not specified | Uncertain significance (Apr 19, 2023) | ||
3-120781090-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
3-120781218-C-T | Benign (Aug 23, 2018) | |||
3-120781352-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
3-120781355-C-T | not specified | Uncertain significance (Jun 27, 2022) | ||
3-120781366-A-G | not specified | Uncertain significance (Jan 24, 2023) | ||
3-120781372-G-T | not specified | Uncertain significance (Mar 01, 2023) | ||
3-120781397-C-A | not specified | Uncertain significance (Aug 23, 2021) | ||
3-120781429-A-G | not specified | Uncertain significance (Jan 07, 2022) | ||
3-120781432-G-A | not specified | Uncertain significance (Nov 17, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GTF2E1 | protein_coding | protein_coding | ENST00000283875 | 4 | 40433 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.892 | 0.107 | 125739 | 0 | 5 | 125744 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.09 | 206 | 255 | 0.808 | 0.0000147 | 2901 |
Missense in Polyphen | 54 | 81.955 | 0.6589 | 1018 | ||
Synonymous | -0.808 | 99 | 89.3 | 1.11 | 0.00000486 | 846 |
Loss of Function | 3.25 | 2 | 16.0 | 0.125 | 0.00000100 | 198 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000442 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Recruits TFIIH to the initiation complex and stimulates the RNA polymerase II C-terminal domain kinase and DNA-dependent ATPase activities of TFIIH. Both TFIIH and TFIIE are required for promoter clearance by RNA polymerase.;
- Pathway
- Basal transcription factors - Homo sapiens (human);Viral carcinogenesis - Homo sapiens (human);Epstein-Barr virus infection - Homo sapiens (human);Eukaryotic Transcription Initiation;Disease;Gene expression (Transcription);the information processing pathway at the ifn beta enhancer;carm1 and regulation of the estrogen receptor;Transcription of the HIV genome;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;HIV Transcription Initiation;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Infectious disease;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;chromatin remodeling by hswi/snf atp-dependent complexes
(Consensus)
Recessive Scores
- pRec
- 0.184
Intolerance Scores
- loftool
- 0.314
- rvis_EVS
- 1.31
- rvis_percentile_EVS
- 94
Haploinsufficiency Scores
- pHI
- 0.753
- hipred
- Y
- hipred_score
- 0.714
- ghis
- 0.428
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.985
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gtf2e1
- Phenotype
Gene ontology
- Biological process
- transcriptional open complex formation at RNA polymerase II promoter;transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;viral process;snRNA transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm;transcription factor TFIID complex;transcription factor TFIIE complex;cytosol;transcriptional preinitiation complex
- Molecular function
- RNA polymerase II complex binding;TFIIH-class transcription factor complex binding;protein binding;sequence-specific DNA binding;metal ion binding